Join the 200th Anniversary Celebration

Correspondence

Older Age and a Reduced Likelihood of 2009 H1N1 Virus Infection

N Engl J Med 2009; 361:2000-2001November 12, 2009

Article

To the Editor:

Early epidemiologic reports regarding the 2009 pandemic influenza A (H1N1) virus suggest that cases of infection and deaths are concentrated in adults between the ages of 20 and 40 years.1 This finding could reflect age-related differences in susceptibility or differential testing and diagnosis in this age group. Increased susceptibility to infection in young persons is characteristic of influenza pandemics and has important implications for disease-control policy.2 We examined whether the reported excess of cases in younger persons derives from testing practices or reflects a differential risk of infection in Ontario, Canada.

Our study sample included all persons who were tested for 2009 H1N1 virus infection under an enhanced, provincewide, laboratory-based surveillance regimen from April 20, 2009, to June 10, 2009. Patients with confirmed infection were compared with those who tested negative for the 2009 H1N1 virus. Using multivariate logistic regression and zero-inflated Poisson regression, we evaluated the association between age group (which was defined according to the relationship between birth year and the predominant circulating influenza strains) and the risk of infection with the 2009 H1N1 virus.

Of 11,560 patients who were tested, 1819 (15.7%) had positive results for the 2009 H1N1 virus. Persons who were born before 1957 had a reduced risk of infection, and estimates did not substantially change after adjustment for travel to Mexico, public health unit of residence, or calendar week (adjusted odds ratio for older age group, 0.15; 95% confidence interval [CI], 0.12 to 0.18; unadjusted odds ratio; 0.17; 95% CI, 0.14 to 0.21). Persons who were born between 1957 and 1975 were at intermediate risk for infection (adjusted odds ratio, 0.42; 95% CI, 0.37 to 0.48). Similar effects were seen in zero-inflated Poisson models that used testing volumes and population as model offsets. There was no significant relationship between age group and the risk of infection with seasonal influenza A viruses (either H3N2 or H1N1) (Figure 1Figure 1Age-Related Probability of Seasonal Influenza A and 2009 H1N1 Influenza in 11,560 Tested Patients.).

Among persons who were at risk for infection with 2009 H1N1 virus, being born before 1957 was associated with a lower infection risk. The reduced number of infections was not simply a reflection of decreased testing in this group. The mechanism for this association is unclear but is compatible with the reported age-related increase in the prevalence of neutralizing antibody titers against the 2009 H1N1 virus3 and may reflect some immunity to infection as a result of exposure to similar viruses in early life. Maximally effective host immune responses to influenza may be generated by early-life infections.4 These findings are consistent with the high frequency of outbreaks of 2009 H1N1 influenza in schools5 and the decreased frequency of outbreaks in long-term care facilities that have been associated with this pandemic virus to date.

David N. Fisman, M.D., M.P.H.
University of Toronto, Toronto, ON, Canada

Rachel Savage, M.Sc.
Jonathan Gubbay, M.B., B.S.
Camille Achonu, M.H.Sc.
Holy Akwar, D.V.M., Ph.D.
David J. Farrell, Ph.D.
Natasha S. Crowcroft, M.B., B.S., Ph.D.
Ontario Agency for Health Protection and Promotion, Toronto, ON, Canada

Phil Jackson, M.A.
468 Delaware Ave., Toronto, ON, Canada

Dr. Fisman reports receiving research support from Sanofi Pasteur. No other potential conflict of interest relevant to this letter was reported.

5 References
  1. 1

    Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-679
    Full Text | Web of Science | Medline

  2. 2

    Miller MA, Viboud C, Olson DR, Grais RF, Rabaa MA, Simonsen L. Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis 2008;198:305-311
    CrossRef | Web of Science | Medline

  3. 3

    Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952
    Full Text | Web of Science | Medline

  4. 4

    Webster RG. Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol 1966;97:177-183
    Web of Science | Medline

  5. 5

    Cutler J, Schleihauf E, Hatchette TF, et al. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 2009;181:159-63

Citing Articles (26)

Citing Articles

  1. 1

    Sanford R. Kimmel. (2011) The Course and Management of the 2009 H1N1 Pandemic Influenza. Primary Care: Clinics in Office Practice 38:4, 693-701
    CrossRef

  2. 2

    X. WANG, X. W. CHENG, H. W. MA, J. F. HE, X. XIE, S. S. FANG, C. L. WU, X. LU, S. J. MEI, Y. LI, J. Q. CHENG. (2011) Influenza surveillance in Shenzhen, the largest migratory metropolitan city of China, 2006–2009. Epidemiology and Infection 139:10, 1551-1559
    CrossRef

  3. 3

    Deborah L. Thompson, Jessica Jungk, Emily Hancock, Chad Smelser, Michael Landen, Megin Nichols, David Selvage, Joan Baumbach, Mack Sewell. (2011) Risk Factors for 2009 Pandemic Influenza A (H1N1)–Related Hospitalization and Death Among Racial/Ethnic Groups in New Mexico. American Journal of Public Health 101:9, 1776-1784
    CrossRef

  4. 4

    GUY KATRIEL. (2011) Note on ‘Age, influenza pandemics and disease dynamics’ by Greer et al. (2010). Epidemiology and Infection 139:09, 1440-1442
    CrossRef

  5. 5

    D. L. Thompson, J. Jungk, E. Hancock, C. Smelser, M. Landen, M. Nichols, D. Selvage, J. Baumbach, M. Sewell. (2011) Risk Factors for 2009 Pandemic Influenza A (H1N1)-Related Hospitalization and Death Among Racial/Ethnic Groups in New Mexico. American Journal of Public Health 101:9, 1776-1784
    CrossRef

  6. 6

    W. Poeppl, M. Hell, H. Herkner, B. Stoiser, G. Fritsche, N. Schurz-Bamieh, G. Poeppl, R. Gattringer, N. Jones, M. Maass, A. Egle, H. Burgmann. (2011) Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria. Infection 39:4, 341-352
    CrossRef

  7. 7

    Abbe N. Vallejo, Robert G. Mueller, David L. Hamel, Amanda Way, Jeffrey A. Dvergsten, Patricia Griffin, Anne B. Newman. (2011) Expansions of NK-like αβT cells with chronologic aging: Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. Ageing Research Reviews 10:3, 354-361
    CrossRef

  8. 8

    Kanwal Kumar, Mina Guirgis, Shelley Zieroth, Evelyn Lo, Alan H. Menkis, Rakesh C. Arora, Darren H. Freed. (2011) Influenza Myocarditis and Myositis: Case Presentation and Review of the Literature. Canadian Journal of Cardiology 27:4, 514-522
    CrossRef

  9. 9

    G. Katriel, R. Yaari, A. Huppert, U. Roll, L. Stone. (2011) Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study. Journal of The Royal Society Interface 8:59, 856-867
    CrossRef

  10. 10

    Sophie A. Valkenburg, John A. Rutigliano, Ali H. Ellebedy, Peter C. Doherty, Paul G. Thomas, Katherine Kedzierska. (2011) Immunity to seasonal and pandemic influenza A viruses. Microbes and Infection 13:5, 489-501
    CrossRef

  11. 11

    Nicolás Nin, Luis Soto, Javier Hurtado, José A. Lorente, María Buroni, Francisco Arancibia, Sebastian Ugarte, Homero Bagnulo, Pablo Cardinal, Guillermo Bugedo, Estrella Echevarría, Alberto Deicas, Carlos Ortega, Fernando Frutos-Vivar, Andrés Esteban. (2011) Clinical characteristics and outcomes of patients with 2009 influenza A(H1N1) virus infection with respiratory failure requiring mechanical ventilation. Journal of Critical Care 26:2, 186-192
    CrossRef

  12. 12

    Seyed M. Moghadas, Nick J. Pizzi, Jianhong Wu, Susan E. Tamblyn, David N. Fisman. (2011) Canada in the face of the 2009 H1N1 pandemic. Influenza and Other Respiratory Viruses 5:2, 83-88
    CrossRef

  13. 13

    Carla Duncan, Jennifer L. Guthrie, Nathalie Tijet, Naglaa Elgngihy, Christine Turenne, Christine Seah, Rachel Lau, Lisa McTaggart, Gustavo Mallo, Stephen Perusini, Anu Rebbapragada, Roberto Melano, Donald E. Low, David Farrell, Cyril Guyard. (2011) Analytical and clinical validation of novel real-time reverse transcriptase–polymerase chain reaction assays for the clinical detection of swine-origin H1N1 influenza viruses. Diagnostic Microbiology and Infectious Disease 69:2, 167-171
    CrossRef

  14. 14

    Hiroshi Nishiura, Alex R. Cook, Benjamin J. Cowling. (2011) Assortativity and the Probability of Epidemic Extinction: A Case Study of Pandemic Influenza A (H1N1-2009). Interdisciplinary Perspectives on Infectious Diseases 2011, 1-9
    CrossRef

  15. 15

    Woo Hyun Cho, Yun Seong Kim, Doo Soo Jeon, Ji Eun Kim, Kun Il Kim, Hee Yun Seol, Ki Uk Kim, Hye Kyung Park, Min Ki Lee, Soon Kew Park, Yeon Joo Jeong. (2011) Outcome of Pandemic H1N1 Pneumonia: Clinical and Radiological Findings for Severity Assessment. The Korean Journal of Internal Medicine 26:2, 160
    CrossRef

  16. 16

    Xiaofan Ding, Lifang Jiang, Changwen Ke, Zhan Yang, Chunliang Lei, Kaiyuan Cao, Jun Xu, Lin Xu, Xingfen Yang, Yonghui Zhang, Ping Huang, Weijun Huang, Xun Zhu, Zhenjian He, Liping Liu, Jun Li, Jie Yuan, Jueheng Wu, Xiaoping Tang, Mengfeng Li. (2010) Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates. Virus Genes 41:3, 329-340
    CrossRef

  17. 17

    D.M.W. Zaiss, C.J.P. Boog, W. van Eden, A.J.A.M. Sijts. (2010) Considerations in the design of vaccines that induce CD8 T cell mediated immunity. Vaccine 28:49, 7716-7722
    CrossRef

  18. 18

    A. L. GREER, A. TUITE, D. N. FISMAN. (2010) Age, influenza pandemics and disease dynamics. Epidemiology and Infection 138:11, 1542-1549
    CrossRef

  19. 19

    M. E. Falagas, N. V. Cholevas, A. M. Kapaskelis, E. K. Vouloumanou, A. Michalopoulos, P. I. Rafailidis. (2010) Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. European Journal of Clinical Microbiology & Infectious Diseases 29:11, 1327-1347
    CrossRef

  20. 20

    Matheus Roriz-Cruz, Idiane Rosset, Manuel Montero-Odasso. (2010) LOWER MORTALITY FROM H1N1 INFLUENZA IN OLDER ARGENTINEANS: MEN MORE AFFECTED. Journal of the American Geriatrics Society 58:9, 1813-1815
    CrossRef

  21. 21

    S. Gras, L. Kedzierski, S. A. Valkenburg, K. Laurie, Y. C. Liu, J. T. Denholm, M. J. Richards, G. F. Rimmelzwaan, A. Kelso, P. C. Doherty, S. J. Turner, J. Rossjohn, K. Kedzierska. (2010) Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proceedings of the National Academy of Sciences 107:28, 12599-12604
    CrossRef

  22. 22

    Hiroshi Nishiura. (2010) Travel and Age of Influenza A (H1N1) 2009 Virus Infection. Journal of Travel Medicine 17:4, 269-270
    CrossRef

  23. 23

    Thomas Henzler, Mathias Meyer, Armin Kalenka, Markus Alb, Gerald Schmid-Bindert, Sönke Bartling, Joseph U. Schoepf, Stefan O. Schoenberg, Christian Fink. (2010) Image Findings of Patients with H1N1 Virus Pneumonia and Acute Respiratory Failure. Academic Radiology 17:6, 681-685
    CrossRef

  24. 24

    Hiroshi Nishiura. (2010) The virulence of pandemic influenza A (H1N1) 2009: an epidemiological perspective on the case–fatality ratio. Expert Review of Respiratory Medicine 4:3, 329-338
    CrossRef

  25. 25

    R. Xu, D. C. Ekiert, J. C. Krause, R. Hai, J. E. Crowe, I. A. Wilson. (2010) Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus. Science 328:5976, 357-360
    CrossRef

  26. 26

    Frank Ramsthaler, Marcel A. Verhoff, Axel Gehl, Mattias Kettner. (2010) The novel H1N1/swine-origin influenza virus and its implications for autopsy practice. International Journal of Legal Medicine 124:2, 171-173
    CrossRef